BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37317583)

  • 21. Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.
    Turan V; Bedoschi G; Emirdar V; Moy F; Oktay K
    Reprod Sci; 2018 Jan; 25(1):26-32. PubMed ID: 28874104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients undergoing elective and oncofertility preservation respond similarly to controlled ovarian stimulation for fertility preservation.
    Kira ATF; Hentschke MR; Vasconcelos NF; Colombo T; Trindade VD; Petracco A; Costa BEPD; Badalotti M
    JBRA Assist Reprod; 2022 Aug; 26(3):407-411. PubMed ID: 35403417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
    Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
    Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.
    Sonigo C; Comtet M; Duros S; Sifer C; Sermondade N; Grynberg M
    J Assist Reprod Genet; 2018 Jan; 35(1):91-97. PubMed ID: 28986734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation.
    Oktay K; Buyuk E; Rodriguez-Wallberg KA; Sahin G
    Reprod Biomed Online; 2010 May; 20(5):634-8. PubMed ID: 20219430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial.
    Letourneau J; Juarez-Hernandez F; Wald K; Ribeiro S; Wang A; McCulloch CE; Mok-Lin E; Dolezal M; Chien AJ; Cedars MI; Rosen M
    J Assist Reprod Genet; 2021 Sep; 38(9):2455-2463. PubMed ID: 34312774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
    Muteshi C; Child T; Ohuma E; Fatum M
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art.
    Bénard J; Duros S; El Hachem H; Sonigo C; Sifer C; Grynberg M
    Future Oncol; 2016 Jul; 12(14):1731-41. PubMed ID: 27184037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fertility preserving methods in women with breast cancer before gonadotoxic therapy].
    Halászová N; Crha I; Huser M; Weinberger V; Žáková J; Ješeta M; Lousová E; Filipinská E; Ventruba P
    Ceska Gynekol; 2017; 82(4):287-292. PubMed ID: 28925272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
    Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes.
    Dolmans MM; Marotta ML; Pirard C; Donnez J; Donnez O
    J Ovarian Res; 2014 Aug; 7():80. PubMed ID: 25296615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation.
    İsrafilova G; Şükür YE; Özkavukcu S; Sönmezer MA; Atabekoğlu CS; Özmen B; Berker B; Aytaç R; Koç A; Sönmezer M
    Reprod Sci; 2021 Aug; 28(8):2200-2207. PubMed ID: 33409878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients.
    Cavagna F; Pontes A; Cavagna M; Dzik A; Donadio NF; Portela R; Nagai MT; Gebrim LH
    Curr Oncol; 2018 Dec; 25(6):e527-e532. PubMed ID: 30607119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments.
    Oktay K; Bedoschi G
    J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):342-6. PubMed ID: 25214440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases-an analysis of 992 stimulations.
    von Wolff M; Bruckner T; Strowitzki T; Germeyer A
    J Assist Reprod Genet; 2018 Sep; 35(9):1713-1719. PubMed ID: 29869766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer grade and stage do not affect fertility preservation outcomes.
    Wald K; Wang A; Abel MK; Morris J; Letourneau JM; Mok-Lin E; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2022 May; 39(5):1155-1161. PubMed ID: 35320444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing the scope of in vitro maturation for fertility preservation: transvaginal retrieval of immature oocytes during endoscopic gynaecological procedures.
    Song XL; Lu CL; Zheng XY; Nisenblat V; Zhen XM; Yang R; Li M; Li R; Yuan YF; Ma CH; Liu P; Feng HL; Yan J; Qiao J
    Hum Reprod; 2020 Apr; 35(4):837-846. PubMed ID: 32154563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.
    Goldman RH; Racowsky C; Farland LV; Munné S; Ribustello L; Fox JH
    Hum Reprod; 2017 Apr; 32(4):853-859. PubMed ID: 28166330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of letrozole administration on oocyte morphology in breast cancer patients undergoing fertility preservation.
    Bercaire LMN; Cavagna M; Donadio NF; Rocha AR; Portela R; Alves VR; Santos TBB; Cavagna F; Dzik A; Gebrim LH; Nahas EAP
    JBRA Assist Reprod; 2020 Jul; 24(3):257-264. PubMed ID: 32293820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.